CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Toledo, S. M.
Right arrow Articles by Little, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Toledo, S. M.
Right arrow Articles by Little, J. B.

Cell Growth & Differentiation, Vol 9, Issue 11 887-896, Copyright © 1998 by American Association of Cancer Research


ARTICLES

Regulation by ionizing radiation of CDC2, cyclin A, cyclin B, thymidine kinase, topoisomerase IIalpha, and RAD51 expression in normal human diploid fibroblasts is dependent on p53/p21Waf1

SM de Toledo, EI Azzam, P Keng, S Laffrenier and JB Little
Department of Cancer Cell Biology, Harvard School of Public Health, Boston, Massachusetts 02115, USA.

Induced cell cycle delays were among the first described cellular responses to ionizing radiation (IR). To understand the sensitivity and the molecular events involved in the response to low doses of IR and to examine the role of p53 and its downstream effector p21Waf1, we measured changes in expression of genes postulated to be involved in the cellular response to IR. Expression levels were examined in normal human diploid fibroblasts irradiated and maintained in quiescent density-inhibited growth up to 24-48 h after exposure to X-ray doses as low as 0.1-0.3 Gy, which have negligible effects on cell survival. Among 31 genes analyzed, we observed down-regulation in response to IR of the mRNA levels of CDC2, cyclin A, cyclin B, thymidine kinase, topoisomerase IIalpha, and RAD51. A similar reduction in the expression levels of these genes occurred when irradiated cells were released from confluence and allowed to proliferate. This was not observed in cells in which p53 function was defective and up-regulation of p21Waf1 levels either did not occur (E6 transfected normal human fibroblasts and Li-Fraumeni fibroblasts) or was delayed (ataxia telangiectasia fibroblasts) after irradiation. Down-regulation was also absent in p21Waf1-null mouse embryo fibroblasts (MEFs) but occurred at a lower level in p53-null MEFs, due to slight increases in p21Waf1 levels by a p53-independent pathway. These findings indicate that the down-regulation of these cell cycle regulated genes in irradiated cells is p53-dependent and involves its effector p21Waf1. Although no down-regulation in the expression of genes involved in G2-M was observed in p53 or in p21Waf1-null MEFs, these cells showed a G2-M delay after irradiation, indicating that the expression levels of these genes does not regulate the G2-M delay.


This article has been cited by other articles:


Home page
JNMHome page
Y. Menda, L. L. Boles Ponto, K. J. Dornfeld, T. J. Tewson, G. L. Watkins, M. K. Schultz, J. J. Sunderland, M. M. Graham, and J. M. Buatti
Kinetic Analysis of 3'-Deoxy-3'-18F-Fluorothymidine (18F-FLT) in Head and Neck Cancer Patients Before and Early After Initiation of Chemoradiation Therapy
J. Nucl. Med., July 1, 2009; 50(7): 1028 - 1035.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Shen, D. M. Moran, and C. G. Maki
Transient Nutlin-3a Treatment Promotes Endoreduplication and the Generation of Therapy-Resistant Tetraploid Cells
Cancer Res., October 15, 2008; 68(20): 8260 - 8268.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Leibowitz-Amit, G. Tsarfaty, Y. Abargil, G. M. Yerushalmi, J. Horev, and I. Tsarfaty
Mimp, a Mitochondrial Carrier Homologue, Inhibits Met-HGF/SF-Induced Scattering and Tumorigenicity by Altering Met-HGF/SF Signaling Pathways.
Cancer Res., September 1, 2006; 66(17): 8687 - 8697.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. Lemke, V. Poindessous, A. Skladanowski, and A. K. Larsen
The Antitumor Triazoloacridone C-1305 Is a Topoisomerase II Poison with Unusual Properties
Mol. Pharmacol., October 1, 2004; 66(4): 1035 - 1042.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S. Polager and D. Ginsberg
E2F Mediates Sustained G2 Arrest and Down-regulation of Stathmin and AIM-1 Expression in Response to Genotoxic Stress
J. Biol. Chem., January 17, 2003; 278(3): 1443 - 1449.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Fletcher, Y. Cheng, and R. J. Muschel
Abolishment of the Tyr-15 Inhibitory Phosphorylation Site on cdc2 Reduces the Radiation-induced G2 Delay, Revealing a Potential Checkpoint in Early Mitosis
Cancer Res., January 1, 2002; 62(1): 241 - 250.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
W. R. Taylor, A. H. Schonthal, J. Galante, and G. R. Stark
p130/E2F4 Binds to and Represses the cdc2 Promoter in Response to p53
J. Biol. Chem., January 19, 2001; 276(3): 1998 - 2006.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. M. Flatt, L. J. Tang, C. D. Scatena, S. T. Szak, and J. A. Pietenpol
p53 Regulation of G2 Checkpoint Is Retinoblastoma Protein Dependent
Mol. Cell. Biol., June 15, 2000; 20(12): 4210 - 4223.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. I. Azzam, S. M. de Toledo, A. J. Waker, and J. B. Little
High and Low Fluences of {{alpha}}-Particles Induce a G1 Checkpoint in Human Diploid Fibroblasts
Cancer Res., May 1, 2000; 60(10): 2623 - 2631.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
B.-D. Chang, K. Watanabe, E. V. Broude, J. Fang, J. C. Poole, T. V. Kalinichenko, and I. B. Roninson
Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: Implications for carcinogenesis, senescence, and age-related diseases
PNAS, April 11, 2000; 97(8): 4291 - 4296.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Badie, J. E. Itzhaki, M. J. Sullivan, A. J. Carpenter, and A. C. G. Porter
Repression of CDK1 and Other Genes with CDE and CHR Promoter Elements during DNA Damage-Induced G2/M Arrest in Human Cells
Mol. Cell. Biol., April 1, 2000; 20(7): 2358 - 2366.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Iyer and B. E. Lehnert
Factors Underlying the Cell Growth-related Bystander Responses to {{alpha}} Particles
Cancer Res., March 1, 2000; 60(5): 1290 - 1298.
[Abstract] [Full Text]


Home page
Mol. Biol. CellHome page
W. R. Taylor, S. E. DePrimo, A. Agarwal, M. L. Agarwal, A. H. Schonthal, K. S. Katula, and G. R. Stark
Mechanisms of G2 Arrest in Response to Overexpression of p53
Mol. Biol. Cell, November 1, 1999; 10(11): 3607 - 3622.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
T. M. Passalaris, J. A. Benanti, L. Gewin, T. Kiyono, and D. A. Galloway
The G2 Checkpoint Is Maintained by Redundant Pathways
Mol. Cell. Biol., September 1, 1999; 19(9): 5872 - 5881.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Schmutte, G. Tombline, K. Rhiem, M. M. Sadoff, R. Schmutzler, A. von Deimling, and R. Fishel
Characterization of the Human Rad51 Genomic Locus and Examination of Tumors with 15q14-15 Loss of Heterozygosity (LOH)
Cancer Res., September 1, 1999; 59(18): 4564 - 4569.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1998 by the American Association of Cancer Research.